SWTX 241220 60.00C (SWTX241220C60000) Stock Options, News & Quotes - Moomoo

US OptionsDetailed Quotes

SWTX241220C60000

Watchlist

0.20
0.000.00%

15min DelayTrading Nov 21 14:50 ET

0.00High0.00Low

Intraday

5D
Daily

News

J.P. Morgan Sticks to Their Buy Rating for Springworks Therapeutics (SWTX)
TipRanksNov 21 07:06 ET · Ratings
SpringWorks Therapeutics Initiated at Outperform by Evercore ISI Group
Dow JonesNov 20 12:10 ET · Ratings
SpringWorks Therapeutics Analyst Ratings
BenzingaNov 20 11:58 ET · Ratings
Evercore Initiates SpringWorks Therapeutics(SWTX.US) With Buy Rating, Announces Target Price $60
Moomoo NewsNov 20 08:33 ET · Ratings
Express News | SpringWorks Therapeutics Inc : JP Morgan Raises Target Price to $70 From $68
ReutersNov 20 00:37 ET
JPMorgan's 'Analyst Focus List' – Growth, Income, Value, Short Ideas
Seeking AlphaNov 19 11:06 ET

Comments

Druckenmiller Stock Portfolio

Stanley Druckenmiller says he's ‘licking my wounds’ from selling Nvidia too soon
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...

Druckenmiller Stock Portfolio

Teach and Learn Together here!

6

Biotech Stock Catalyst Watchlist 👀

🎯 Ph 2 readouts in Q2 2024...
$Iovance Biotherapeutics (IOVA.US)$ Phase 2
$Supernus Pharmaceuticals (SUPN.US)$ Phase 2a
$BRANDES INTERNATIONAL ETF (BINV.US)$ Phase 2a
$MorphoSys (MOR.US)$ Phase 2
$Nuvation Bio (NUVB.US)$ Phase 2
$ALX Oncology (ALXO.US)$ Phase 2
$BioXcel Therapeutics (BTAI.US)$ Phase 2
$Purple Biotech (PPBT.US)$ Phase 2
$Arcus Biosciences (RCUS.US)$ Phase 2
$Medicenna Therapeutics (MDNAF.US)$ Phase 2b
$Affimed NV (AFMD.US)$ Phase 2
$Barinthus Biotherapeutics (BRNS.US)$ Phase 2b...

Biotech Stock Catalyst Watchlist 👀

Biotech Stock Catalyst Watchlist 👀

16

3

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

8

Gear up for AACR24!

See Biotech companies with cancer assets 👇
⇨ held by 5 biopharma-focused hedge funds! 🔥
$Arcellx (ACLX.US)$ : Anito-cel (Ph 2)
$Adaptimmune Therapeutics (ADAP.US)$ : Afami-cel (PDUFA) ⏳
$Bicycle Therapeutics (BCYC.US)$ : BT8009 (Ph 1/2)
$Centessa Pharmaceuticals (CNTA.US)$ : LB101 (Ph 1/2)
$Day One Biopharmaceuticals (DAWN.US)$ : Tovorafenib (PDUFA) (check comments for details)
$Fate Therapeutics (FATE.US)$ : FT576 (Ph 1)
$Fusion Pharmaceuticals (FUSN.US)$ : FPI-2265 (Ph 2)
$GRCL: ...

9

1

Dec 4, 2023 15:33

$SpringWorks Therapeutics (SWTX.US)$ nice go down so i can get some

Read more